Josh is a clinician researcher, and divides his time between clinical work as an Infectious Diseases physician in Newcastle, and research work as a principal research fellow based at Menzies.
He completed his clinical infectious diseases training in 2004, and then worked on a PhD from 2007-2010 on the epidemiology, pathophysiology and adjunctive treatment of sepsis in the Top End of the Northern Territory (NT).
His main clinical interests are general infectious diseases, viral hepatitis, refugee health and infections in the critical care setting. His main research interests are clinical trials in the management of severe infections and epidemiology of severe bacterial infections.
Josh is the past president of the Australasian Society for Infectious Diseases (ASID) and is a career development fellow of Australia's National Health and Medical Research Council. In the 10 years since completing his PhD, he has over 140 peer-reviewed publications and an h-index of 31.
Prf. Chengming Fan is a Surgeon in the Department of Cardiovascular Surgery at Central South University. HIs current basic research interests include treatment of ischemic heart disease with human induced pluripotent stem cells (hiPSC)-related strategy and with preclinical animal models.
Dr. Tamàs Fülöp is Assistant Director of the Age Research Centre and Full Professor within the Faculty of Medicine and Health Sciences at the Université de Sherbrooke in Quebec, Canada. He is also Head of the Immune Inflammation Laboratory and Medical Director of the Memory Clinic.
M.D: From the Unversity of Geneva.
His postdoctoral research was in the biochemistry of connective tissues, and his PhD is in immunology and gerontology. His research interest is aging in relation to immunity.
Dr. Bang-Gee Hsu obtained his MD from the Chinese Medical University, Taichung, Taiwan (1989 - 1996) and his PhD from the Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan (2003-2006).
Dr. Hsu is currently Professor at the School of Medicine, Tzu Chi University, Hualien, Taiwan (2015-present), Director of the Department of Internal Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan (2018-present), and Director of the Division of Nephrology Department of Internal Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan (2014-present).
His research interests include Nephrology, Critical Care Medicine and Internal Medicine.
Dr. Lei Huang is a cancer epidemiologist, translational oncologist, digestive surgeon, surgical oncologist, and gastroenterologist. He has published about 50 papers in SCI(E)-indexed journals including Gut, Annals of Surgery, BMC Medicine, JAMA Surgery, Clinical Cancer Research, Cancer Immunology Research, International Journal of Cancer, EBioMedicine, and Gastric Cancer. His works have been cited for about 1000 times.
Dr. Huang has served on the editorial board of Frontiers in Oncology, World Journal of Gastrointestinal Oncology, PeerJ, Medicine, and Translational Cancer Research, and Frontiers in Surgery. He has been peer reviewer for about 50 SCI(E)-indexed journals including Annals of Internal Medicine, Annals of Surgery, Clinical Cancer Research, Journal of the National Comprehensive Cancer Network-JNCCN, Cancer Letters, Oncoimmunology, and Oncologist. He was selected as Best Reviewer for Annals of Internal Medicine twice in 2017 and 2019.
Dr. Huang has been invited to give oral presentations in the ASCO Annual Meeting and International Gastric Cancer Congress (IGCC), and has received Merit Awards in the ESMO Annual Meeting and Awards for Young Investigators in the IGCC.
His research interests majorly cover the epidemiological, clinical, and translational aspects of digestive cancers. He has successfully coordinated several large international investigations with participants from the US and about 20 European countries.
Professor and Director of the Degenerative Diseases at the Sanford-Burnham Medical Research Institute, La Jolla, CA. Formerly Professor of Biological Chemistry and Internal Medicine and Investigator of the Howard Hughes Medical Research Institute at the University of Michigan Medical School. Awards include the Murray Thelin Award, the ìPrix Henri Chaigneauî, the ISTH Investigator Recognition Award , the ESACT Van Wezel Prize, and fellow of the AAAS.
Prof. Marunaka is the President and the Representative Director, Director of Clinical, and Director of Medical Research Institute, Kyoto Industrial Health Association; Professor, Research Organization of Science and Technology, Ritsumeikan University; Professor Emeritus, Kyoto Prefectural University of Medicine; Former President, Physiological Society of Japan. Former President, International Society of Cancer Metabolism. MD (1979), PhD (1985), Kyoto Prefectural University of Medicine; National License of Physician and Surgeon, Japan (1979). He was Professor and Chairperson, Departments of Molecular Cell Physiology and Bio-Ionomics, Kyoto Prefectural University of Medicine, Japan, and Director and Professor, Japan Institute for Food Education and Health, St. Agnes’ University. He was awarded “Vebleo Nanomedicine Scientist Award” (Sweden), “Marco Polo della Scienza Italiana” (Italy), The Premier's Research Excellence Award (Canada), Scholar Award (Medical Research Council of Canada) and Research Award from National Kidney Foundation of USA. He has obtained more than 60 research grants, published more than 270 peer reviewed articles, and provided more than 30 invited plenary lectures at international congresses and research conferences. h-index 47, i10-index 190, Citation 7498
Dr. Ghanshyam Palamaner Subash Shantha is an academic cardiac electrophysiologist and faculty physician at Wake Forest University. His clinical interests include atrial fibrillation, leadless pacemakers and ventricular tachycardia management, and his research interests include epidemiology and prevention of diseases.
Dr. Pan is a Senior Research Fellow at Menzies Institute for Medical Research. He has been researching both epidemiology and clinical interventions to osteoarthritis-related pain. Much of his work has been on identifying biomechanical risk factors for chronic pain and osteoarthritis, identifying pain and osteoarthritis phenotypes and testing new therapeutic treatments.
Associate Professor in Internal Medicine, Dept. Medicine, University of Padova, Italy.
International PhD Degree in 'Arterial Hypertension and Vascular Biology'.
Field of interest: Clinical and translational research in high blood pressure and cardiovascular diseases.
Dr. Rajesh Kumar Singh received his BPharm (2003) and MPharm (2005) from UIPS, Panjab University, Chandigarh. He started to teach pharmaceutical chemistry at the Shivalik College of Pharmacy, Nangal, in 2006, where he completed his PhD in 2013 from IKG Punjab Technical University (IKGPTU), Jalandhar. His major areas of research interest are computer-aided drug-design, polymer-drug conjugates for targeted delivery to CNS and cancerous cells, antimalarial therapeutic agents, and green chemistry approaches for chemical synthesis. Dr. Singh has over 15 years of teaching experience and has guided one 03 Ph.D. and 20 PG students. He is currently guiding 02 PhDs and 02 MPharm students. He has published more than 70 peer-reviewed SCI/SCOPUS-indexed scientific papers with a total JCR Impact Factor of more than 200 in various chemistry and pharmacy journals such as European Journal of Medicinal Chemistry, Acta Pharmaceutica Sinica-B, Bioorganic Chemistry, Biomedicine and Pharmacotherapy, Pharmaceutical Research, European Journal of Pharmaceutical Sciences, Mini-Reviews in Medicinal Chemistry, Pharmaceutical Research, Med. Chem. Res., J. Enzyme Inhi. Med Chem., Res. Chem. Intermediate etc as main or corresponding author. He currently serves as an Editorial Advisory Board Member of 10 international journals, including the SCI-indexed MRMC (Bentham) and PeerJ. He has received the Publon Award 2016, 2017 and the Publon "Excellent Peer Reviewer Award" for outstanding reviewing of more than 290 research papers in different international journals of ACS, RSC, Springer, Elsevier, Dove, Informa, and Bentham whose Impact Factor varies from 1.0 to 12.5. He also has over 60 National and International Conference Abstracts, 5 Books, 5 Best Paper Presentation Awards, 1 Travel Grant to attend International Conferences, and 5 Research Projects funded by Indian Government Agencies. He is also on the panel of international reviewers for research proposals for Royal Society Grants. He is also serving as a PUBLON ACADEMY MENTOR and a BENTHAM BRAND AMBASSADOR. He has been recognized by the Editors as an OUTSTANDING REVIEWER for RSC Medicinal Chemistry journal (IF 4.1, Q1) and also for BENTHAM PUBLISHER in 2023. His name is recently featured in the list of top 2% scientists (2023) ranked by team of Stanford University, USA and Elsevier.
Dr. Jincheng Wang is a research fellow at global center for Biomedical Science and Engineering, Hokkaido University Faculty of Medicine. Dr. Jincheng Wang worked as a hepatologist in Nanjing Drum Tower Hospital for 3 years. He published 29 articles and obtained more than 10 patents (https://orcid.org/0000-0001-9345-2388). His research interests are natural products, cancer treatment, radiomics, medical informatics and computational methods in personalized medicine.